Historical record - last NADAC effective date: 2/21/2024
Product Information
TERBINAFINE HCL 250 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.1544 per EA under NDC 69097073107. Its NADAC has been published 157 times since Feb 24, 2021.
FDA first approved this application on Jul 2, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
250 mg/1
Manufacturer
Cipla USA Inc.NDC
69097073107
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
2/21/2024
Active Ingredients
TERBINAFINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077137FDA Approved
7/2/2007
TE Code
AB
On Market Since
1/8/2021
Pharmacological Classes
Price Statistics
The NADAC for TERBINAFINE HCL 250 MG TABLET has been published 157 times since Feb 24, 2021, and over the history we have for it it has declined 6.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1544 per EA |
|---|---|
| All-time high | $0.1777 (Aug 11, 2021) |
| All-time low | $0.1441 (Jan 17, 2024) |
| Median price | $0.1593 |
| Average price | $0.1599 |
| Largest weekly change | -9.3% (Aug 23, 2023) |
| Weeks tracked | 157 |
| Tracking since | Feb 24, 2021 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-3.1%
5Y
-11.4%
All
-6.7%
Last surveyed Feb 21, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TERBINAFINE HCL 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TERBINAFINE HCL 250 MG TABLET, manufactured by Cipla USA Inc., is $0.1544 per EA (NDC 69097073107), effective Feb 21, 2024.
How has the price of TERBINAFINE HCL 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for TERBINAFINE HCL 250 MG TABLET has declined 6.7%. It has been tracked across 157 weekly CMS publications since Feb 24, 2021.
What are the highest and lowest recorded NADAC prices for TERBINAFINE HCL 250 MG TABLET?
Since Feb 24, 2021, the NADAC for TERBINAFINE HCL 250 MG TABLET has ranged from a low of $0.1441 (Jan 17, 2024) to a high of $0.1777 (Aug 11, 2021), with a median of $0.1593 per EA.
Are there cheaper alternatives to TERBINAFINE HCL 250 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TERBINAFINE HCL 250 MG TABLET, is $0.1513 per EA — about 2% below TERBINAFINE HCL 250 MG TABLET.
Who manufactures TERBINAFINE HCL 250 MG TABLET?
TERBINAFINE HCL 250 MG TABLET (NDC 69097073107) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.